Quick answers
- What is Kirsty?
- Kirsty is a brand name of Insulin aspart, a prescription medicine. The FDA NDC Directory lists 2 Kirsty products in 1 strength and form.
- Who makes Kirsty?
- Biocon Biologics Inc holds the FDA application for Kirsty (BLA761188, approved July 15, 2025).
- Is there a generic or store brand of Kirsty?
- Yes. The FDA NDC Directory lists 23 other products with the same active ingredients, strength and form as a Kirsty product. Ask your pharmacist whether one is right for you.
- Has Kirsty been recalled?
- No recall linked to Kirsty products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Kirsty is
Each Kirsty product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Insulin aspart · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| insulin aspart 100 units/mL injection, solution (intravenous, subcutaneous) | Kirsty | 23 products, 6 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Insulin aspart →
FDA approval
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| BLA761188 | Biocon Biologics Inc | July 15, 2025 | 2 |
Companies that list Kirsty
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Kirsty products.
- Biocon Biologics Inc.2 products
Recalls
No recall linked to Kirsty products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.